# Kyverna Therapeutics, Inc. (KYTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KYTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -165.16M | $ -157.99M | $ 29.03M | $ 232.28M |
| 2024 | $ 0 | $ -105.96M | $ -122.40M | $ 8.24M | $ 266.59M |
| 2023 | $ 0 | $ -65.27M | $ -57.34M | $ 9.08M | $ 49.18M |
| 2022 | $ 315.0K | $ -9.49M | $ -9.86M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.12 |
| Liabilities / Eq | 0.26 |
| Current Ratio | 7.75 |

## Other views

- [Metrics](https://sponda.capital/en/KYTX.md)
- [Charts](https://sponda.capital/en/KYTX/charts.md)
- [Compare](https://sponda.capital/en/KYTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.